Pharmaceutical Contract Manufacture
Organization
Market
Pharmaceutical Contract Manufacture Organization
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Pharmaceutical Contract Manufacture Organization
Market Size and Growth
The Pharmaceutical Contract Manufacturing Organization (CMO) market is experiencing robust growth, driven by increasing pharmaceutical production outsourcing and rising demand for biologics. The market size is projected to reach approximately $120 billion by 2027, with a compound annual growth rate (CAGR) of around 6% from 2022 to 2027.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Lonza
◍ Boehringer Ingelheim
◍ Catalent
◍ Baxter
◍ AbbVie
◍ Pfizer
◍ Evonik
◍ Fareva group
◍ Aenova
◍ Almac
◍ Delpharm
◍ Recipharm
◍ Aesica
◍ NIPRO CORPORATION
◍ Daito Pharmaceutical
◍ Teva API
◍ Esteve Quimica
The Pharmaceutical Contract Manufacture Organization (CMO) market features key players like Lonza, Boehringer Ingelheim, and Catalent, leveraging their expertise in drug development and production. These companies enhance market growth by providing tailored manufacturing solutions, improving efficiency, and reducing costs. Sales revenues are influenced by growing outsourcing trends and innovation in pharmaceuticals.
◍ Euticals
Request Sample Report
Market Segmentation
By Application
By Product
◍ Active Pharmaceutical Ingredients (APIs) ◍ Finished Dose Formulations (FDFs) ◍ Specialty/Midsize
Generics ◍ Big Pharma
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
